Are there any side effects of taking Eltrombopag for a long time?
Blood system: By inhibiting the breakdown of platelets and promoting their production, eltrombopag may lead to enhanced blood coagulation, thereby increasing the risk of thrombosis. This includes serious conditions such as deep vein thrombosis and pulmonary embolism. In addition, long-term use may cause abnormally high platelet counts.
Nervous system: Eltrombopag may cause an increase in intracranial pressure, leading to cerebral edema, which may lead to headache, dizziness, blurred vision and other symptoms. When severe, these symptoms may affect the patient's ability to perform daily life and work.
Digestive system: Eltrombopag may stimulate the smooth muscles of the gastrointestinal tract, causing gastrointestinal dysfunction, leading to digestive system symptoms such as nausea, vomiting, loss of appetite, and stomach discomfort.
Skin reaction: Some patients may have allergic reactions to eltrombopag, manifesting as rash, itching, redness and swelling. In severe cases, it may be accompanied by skin peeling, urticaria, etc.
Hepatotoxicity: Prolonged use of eltrombopag may cause damage to the liver and cause elevated transaminase levels. If left untreated, long-term liver function damage may lead to the progression of chronic liver disease.
Immune system: Eltrombopag may affect the body's immune function, leading to infection, fever and other immune-related symptoms.
Musculoskeletal system: Patients taking eltrombopag for a long time may experience symptoms such as myalgia, muscle spasm, and musculoskeletal pain.
Others: Eltrombopag may also cause fatigue, anemia, insomnia, menstrual disorders, constipation and other side effects. The severity and incidence of these side effects vary between individuals.
Patients should closely monitor platelet counts and other laboratory indicators while taking eltrombopag to detect and manage potential side effects early. If severe or persistent side effects occur, you should consult your doctor immediately to adjust the treatment plan or discontinue the drug. Eltrombopag should be used under the guidance of a doctor and avoid increasing or decreasing the dose or discontinuing the drug on your own.
[ 免责声明 ] 本页面内容来自公开渠道(如FDA官网、Drugs官网、原研药厂官网等),仅供持有医疗专业资质的人员用于医学药学研究参考,不构成任何治疗建议或药品推荐。所涉药品可能未在中国大陆获批上市,不适用于中国境内销售和使用。如需治疗,请咨询正规医疗机构。本站不提供药品销售或代购服务。
.jpeg)